Literature DB >> 11408013

Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines.

P M Jacobson Brown1, M G Neuman.   

Abstract

Hepatitis C virus is a common cause of hepatocellular injury that is associated with complex and vigorous immunologic mechanisms. Both humoral and cell-mediated immune responses participate in the host defense against hepatitis C viral infection, but there is increasing recognition of the roles played by the cell-mediated response, and in particular the cytokine system, in the immunopathogenesis of chronic hepatitis C. The cell-mediated response depends on cytotoxic and helper T-cell activity, and functions through the actions of cytokines to regulate macrophages, natural killer cells, and antiviral cellular proteins. Cytokines produced in the liver are essential in defending the host against hepatitis C invasion, but they have also been implicated in the hepatocellular injury seen in the majority of chronically infected patients. Cytokines are thought to be involved in the pathogenesis of hepatitis C under conditions where the virus can mutate effectively and evade T-cell immune defense mechanisms. Persistent infection upsets the balance between immunostimulatory and inhibitory cytokines which can prolong inflammation and lead to necrosis, fibrosis, and chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408013     DOI: 10.1016/s0009-9120(01)00210-7

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  30 in total

Review 1.  Review of cytokine profiles in patients with hepatitis.

Authors:  Qiao-Ling Sun; Wei Ran
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

2.  Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Jeffrey Samet
Journal:  AIDS Care       Date:  2012-01-24

3.  Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.

Authors:  Jason T Blackard; Minhee Kang; Kenneth E Sherman; Margaret James Koziel; Marion G Peters; Raymond T Chung
Journal:  J Interferon Cytokine Res       Date:  2006-11       Impact factor: 2.607

4.  Does Fasciola hepatica infection modify the response of acute hepatitis C virus infection to IFN-alpha treatment?

Authors:  Mehmet Sahin; Mehmet Isler; Altug Senol; Mustafa Demirci; Zeynep Dilek Aydin
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 5.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

6.  Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.

Authors:  Daniel Fuster; Debbie M Cheng; Emily K Quinn; Kaku A Armah; Richard Saitz; Matthew S Freiberg; Jeffrey H Samet; Judith I Tsui
Journal:  AIDS       Date:  2014-04-24       Impact factor: 4.177

7.  Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.

Authors:  Curtis Cooper; Stephan Shafran; Susan Greenbloom; Robert Enns; John Farley; Nir Hilzenrat; Kurt Williams; Magdy Elkashab; Nabil Abadir; Manuela Neuman
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-08

8.  Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.

Authors:  Daniel Fuster; Judith I Tsui; Debbie M Cheng; Emily K Quinn; Kaku A Armah; David Nunes; Matthew S Freiberg; Jeffrey H Samet
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-17       Impact factor: 2.205

9.  Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.

Authors:  A Bharat; F Barros; K Narayanan; B Borg; M Lisker-Melman; S Shenoy; J Lowell; J Crippin; W Chapman; T Mohanakumar
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

10.  Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Authors:  Abdel-Rahman N Zekri; Hanaa M Alam El-Din; Abeer A Bahnassy; Naglaa A Zayed; Waleed S Mohamed; Suzan H El-Masry; Sayed K Gouda; Gamal Esmat
Journal:  Comp Hepatol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.